From: Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
odds ratio | P -value | odds ratio | P -value | |
Female sex (n= 222) | 1.594 (0.926–2.742) | 0.092 | ||
Age, y (n= 222) | 1.009 (0.982–1.037) | 0.522 | ||
Onset age, y (n= 222) | 1.000 (0.974–1.027) | 0.992 | ||
Duration of disease, y (n= 222) | 1.100 (1.000–1.208) | 0.049* | ||
Education, y (n= 222) | 0.935 (0.864–1.011) | 0.091 | ||
LEDD (mg/day) (n= 222) | 1.001 (1.000–1.002) | 0.083 | ||
H-Y stage (n= 222) | 1.578 (1.102–2.258) | 0.013* | ||
UPDRS total score (n= 222) | 1.033 (1.018–1.048) | <0.001* | ||
UPDRS part I (n= 222) | 1.333 (1.159–1.533) | <0.001* | ||
UPDRS part II (n= 222) | 1.122 (1.059–1.189) | <0.001* | ||
UPDRS part III (n= 222) | 1.036 (1.016–1.056) | <0.001* | ||
UPDRS part IV (n= 222) | 1.210 (1.049–1.396) | 0.009* | ||
HAMD score (n= 177) | 1.079 (1.016–1.146) | 0.013* | ||
PDSS (n= 177) | 0.967 (0.954–0.981) | <0.001* | 0.974 (0.959–0.989) | 0.001 |
MoCA score (n= 222) | 0.948 (0.890–1.009) | 0.094 |